临床医学名词词典

名词信息

中文名: 冠状动脉分叉病变单个非药物洗脱支架置入术

英文名: single non drug eluting stent implantation for bifurcation lesion of coronaiy artery

中文又称:

中文曾称:

名词来源:

所属专业: 心血管外科

所属类别: 手术操作名词

加入我的词汇本

Pubmed相关的文献

single non drug eluting stent implantation for bifurcation lesion of coronaiy artery相关文献:

Clinical outcomes of a dedicated bifurcation stent system.

Sivalingam J, Mazhar MW, Chaddad RA, Fouladvand F, Cortese B.

Cardiovasc Revasc Med. 2024 Feb;59:21-26. doi: 10.1016/j.carrev.2023.08.015. Epub 2023 Aug 31.

PMID:37666716

[Interventional cardiology].

Albarrán A, Pinar E, Baz JA, Mauri J.

Rev Esp Cardiol. 2008 Feb;61 Suppl 1:72-85.

PMID:18341937

Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?

Dash D, Mody R, Ahmed N, Malan SR, Mody B.

Indian Heart J. 2022 Nov-Dec;74(6):450-457. doi: 10.1016/j.ihj.2022.10.193. Epub 2022 Nov 5.

PMID:36347323

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel MA, Serruys PW, Gil RJ.

EuroIntervention. 2020 Oct 23;16(8):654-662. doi: 10.4244/EIJ-D-19-00361.

PMID:31543500

Very long-term clinical outcomes after percutaneous coronary intervention for complex vs non-complex lesions: 10-year outcomes following sirolimus-eluting stent implantation.

Riku S, Suzuki S, Yokoi T, Sakaguchi T, Yamamoto T, Jinno Y, Tanaka A, Ishii H, Inden Y, Murohara T.

Nagoya J Med Sci. 2022 May;84(2):352-365. doi: 10.18999/nagjms.84.2.352.

PMID:35967938

Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.

Somsen YBO, Rissanen TT, Hoek R, Ris TH, Stuijfzand WJ, Nap A, Kleijn SA, Henriques JP, de Winter RW, Knaapen P.

Catheter Cardiovasc Interv. 2025 Feb;105(2):494-516. doi: 10.1002/ccd.31316. Epub 2024 Dec 11.

PMID:39660933

Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.

Naganuma T, Kawamoto H, Panoulas VF, Latib A, Tanaka A, Mitomo S, Ruparelia N, Jabbour RJ, Chieffo A, Carlino M, Montorfano M, Colombo A.

Int J Cardiol. 2017 Nov 1;246:26-31. doi: 10.1016/j.ijcard.2017.03.123.

PMID:28867010

Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.

Capranzano P, Gargiulo G, Capodanno D, Longo G, Tamburino C, Ohno Y, Attizzani GF, La Manna A, Di Salvo M, Francaviglia B, Grasso C, Sgroi C, Tamburino C.

Minerva Cardioangiol. 2014 Jun;62(3):229-34.

PMID:24831758

Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.

Kim WJ, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2011 May 1;77(6):775-82. doi: 10.1002/ccd.22915. Epub 2011 Jan 4.

PMID:21520380

Very long-term outcomes following drug-eluting stent implantation for unprotected left main coronary artery stenosis: a single center experience.

Ielasi A, Latib A, Chieffo A, Takagi K, Mussardo M, Davidavicius G, Godino C, Carlino M, Montorfano M, Colombo A.

Rev Esp Cardiol (Engl Ed). 2013 Jan;66(1):24-33. doi: 10.1016/j.recesp.2012.06.026. Epub 2012 Oct 5.

PMID:23041167